Cite this paper
Tran, D. , Clothier, H. , Buttery, J. and Crawford, N. (2012) Surveillance of adverse events following H1N1/09 influenza immunisation in Victoria, Australia. Natural Science
, 1065-1073. doi: 10.4236/ns.2012.412135
 Patterson, K.D. and Pyle, G.F. (1991) The geography and mortality of the 1918 influenza pandemic. Bulletin of the History of Medicine, 65, 4-21.
 Peiris, J.S., Poon, L.L. and Guan, Y. (2009) Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. Journal of Clinical Virology, 45, 169-173.
 Souayah, N., et al. (2007) Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Vaccine, 25, 5253-5255. doi:10.1016/j.vaccine.2007.03.053
 Haber, P., et al. (2004) Guillain-Barre syndrome following influenza vaccination. Journal of the American Medical Association, 292, 2478-2481.
 Nolan, T., et al. (2010) Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: A randomized trial. Journal of the American Medical Association, 303, 37-46. doi:10.1001/jama.2009.1911
 Therapeutic Goods Administration (2009) TGA approves vaccine against Pnademic (H1N1) 2009 influenza.
 Department of Health Ageing (2010) The Facts on swine flu. D.o.H. Ageing, Canberra.
 National Health and Medical Research Council (2008) The Australian Immunisation Handbook. 9th Edition, National Capital Press, Canberra.
 Clothier, H.J., et al. (2011) Surveillance of adverse events following immunisation: The model of SAEFVIC, Victoria. Communicable Diseases Intelligence, 35, 294-298.
 Therapeutic Goods Administration (2010) Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children.
 Van Buynder, P.G., et al. (2011) Marketing paediatric influenza vaccination: Results of a major metropolitan trial. Influenza and Other Respiratory Viruses, 5, 33-38.
 Armstrong, P.K., et al. (2011) Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine. BMJ Open, 1, e000016.
 Bishop, J. (2010) Seasonal influenza vaccine and young children. D.o.H.a. Ageing, Canberra.
 Therapeutic Goods Administration (2010) Investigation into Febrile Convulsions in young children after Seasonal Influenza Vaccination. Latest findings and recommendations 30th July 2010. D.o.H.a. Ageing, Canberra.
 Stokes, B. (2010) Ministerial review into the public health response into the adverse events to the seasonal influenza vaccine. D.o.H. Government of WA, Canberra.
 Surveillance of adverse events following vaccination in the community. SAEFVIC adverse events reporting, 2007. http://www.saefvic.org.au
 Australian Bureau of Statistics (2008) Population projections Australia 2006-2101.
 Australian Institute of Health and Wellbeing (2011) 2009 adult vaccination survey: Summary results. Cat. no. PHE 135. http://www.aihw.gov.au/publication-detail/?id=10737418409
 Australian Institute of Health and Wellbeing (2010) 2010 pandemic vaccination survey: Summary results. Cat. no. PHE128. http://www.aihw.gov.au/workarea/downloadasset.aspx?id=6442460016
 Mak, D.B., et al., Pandemic (H1N1) 2009 influenza vaccination coverage in Western Australia. Med J Aust, 2010. 193(7): p. 401-4.
 Mahajan, D., et al., (2010) Annual report: Surveillance of adverse events following immunisation in Australia, 2009. Communicable Diseases Intelligence, 34, 259-276.
 Vellozzi, C., et al., (2010) Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine, 28, 7248-7255. doi:10.1016/j.vaccine.2010.09.021
 Liang, X.F., et al. (2011) Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China. The New England Journal of Medicine, 364, 638-647.
 Gosbell, I.B., et al. (2010) Immunisation and multi-dose vials. Vaccine, 28, 6556-6561.
 Evans, D., Cauchemez, S. and Hayden, F.G. (2009) “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barre syndrome, and the detection of rare severe adverse events. The Journal of Infectious Diseases, 200, 321-328. doi:10.1086/603560
 Hughes, R.A. and D.R. Cornblath, (2005) Guillain-Barre syndrome. Lancet, 366, 1653-1666.
 Department of Health Ageing (2011) Review of Australia’s health sector response to pandemic (H1N1) 2009, lessons identified. D.o.H.a, Canberra.
 Crawford, N.W. (2011) GBS active: Targeted active surveillance for Guillain-Barre syndrome following the introduction of H1N1 vaccines in victoria, Australia. World Society of Paediatric Infectious Diseases Conference, Melbourne, 16-19 November 2011.
 Blyth, C.C., et al. (2011) Trivalent influenza vaccine and febrile adverse events in Australia, 2010: Clinical features and potential mechanisms. Vaccine, 29, 5107-5113.
 Horvath, J. (2010) Review of the management of adverse events associated with Panvax and Fluvax. D.o.H. Ageing, Canberra.
 Kelly, H.A., et al. (2011) Adverse events associated with 2010 CSL and other inactivated influenza vaccines. Medical Journal of Australia, 195, 318-320.
 Department of Health Ageing (2010) Summary of ATAGI recommendations for selection of seasonal influenza vaccine for children >6 months to <5 years, adults and other risk groups.
 Centers for Disease Control and Prevention (2010) Media statement: ACIP recommendation for use of CSL influenza vaccine.